Please login to the form below

Not currently logged in
Email:
Password:

Patent

This page shows the latest Patent news and features for those working in and with pharma, biotech and healthcare.

Takeda rebels take aim at Shire acquisition

Takeda rebels take aim at Shire acquisition

Christophe Weber. Weber has already taken steps to solve Takeda’s biggest problems of a lacklustre pipeline and patent expiries on big-selling brands with aggressive international expansion and a series

Latest news

More from news
Approximately 84 fully matching, plus 1,056 partially matching documents found.

Latest Intelligence

  • Can new data aggregators shift the balance of power away from pharma? Can new data aggregators shift the balance of power away from pharma?

    However, it was only 20 years ago that several genomics companies, led by Human Genome Sciences Inc, thought they could secure a monopoly position over unprecedented drug targets by filing patents

  • Mylan sees the UK paving the way for an insulin game changer Mylan sees the UK paving the way for an insulin game changer

    The dream is that, on Day One when the product loses its patent, 100% of the patients use the biosimilar and the opportunity has been optimised. ... biosimilar and the promise of Mylan’s pipeline, which is fuelled by an annual Research &Development

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    No new classes of antibiotics have been introduced for more than 30 years and antibiotic patent applications worldwide.

  • Deal Watch January 2018

    Licence. 217. Teva Pharmaceuticals/ Alder Biopharmaceuticals. Patents covering anti-calcitonin gene-related peptide (CGRP) antibodies and methods - eptinezumab (p3). † ... Patent settlement, non-exclusive licence. 200. Mallinckrodt/Baxter International.

  • Drug R&D

    Healthcare terms - Drug R&D.

More from intelligence
Approximately 2 fully matching, plus 103 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 10 partially matching documents found.

Latest from PMHub

  • Mastering the precision medicine opportunity

    Tech companies like Amazon, Verily, Apple and Microsoft are all registering patents for healthcare tools or software as they seek to gain entry into the healthcare space.

  • Random42 appoints Bill Collis as Chairman

    Bill's leadership skills earned him an Ernst &Young Entrepreneur Of The Year award in 2012 and he is also the proud owner of numerous patents, a major feature movie credit,

  • Indians scalp cowboys in patent war

    Indians scalp cowboys in patent war. An unlikely treaty between global pharma and native Americans. ... At the same time, imaginative patent lawyers will be racking their brains to exploit new opportunities.

  • Global Corporate Divestment Study

    Expiring patents along with regulatory and reimbursement changes were significant divestment drivers.

  • Biosimilars: Getting the flock to market

    Patents were protected and intellectual property was defended. This is hardly surprising, as billions are at stake - Remicade alone earned Johnson &Johnson over $6bn a year, while Humira is responsible for ... Humira alone has more than a dozen

More from PMHub
Approximately 2 fully matching, plus 38 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Solaris Health

The beauty of detail: an effective, compelling medical communications campaign requires each component to be carefully planned, expertly crafted and...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics